Other Hereditary Red-Cell Membrane Disorders

Article written and reviewed by Dr Luca Moretti

The other hereditary red-cell membrane disorders are a heterogeneous and complex group of congenital red-cell membrane disorders. They include mainly structural and/or functional membrane abnormalities distinct from hereditary spherocytosis, while some entities discussed here, such as hereditary pyropoikilocytosis, belong to the hereditary elliptocytosis spectrum. Although they share a nonimmune basis and may be associated with chronic hemolysis, each disorder is defined by specific molecular defects, distinct pathogenic mechanisms and remarkably broad clinical variability, making diagnosis and management particularly challenging.

Among the best recognized and studied forms are hereditary stomatocytoses, including overhydrated and dehydrated forms (hereditary xerocytosis), hereditary pyropoikilocytosis, Southeast Asian ovalocytosis, as well as rare forms caused by combined membrane-protein defects and some conditions still undergoing molecular reclassification.

Knowledge of these disorders, once regarded mainly as morphological curiosities, is now clinically important for the differential diagnosis of chronic hemolytic anemias, prognostic and therapeutic decisions such as management of thrombotic complications, and accurate family genetic counseling, especially in multicultural settings and among people who have migrated from endemic regions.

Etiology, Pathogenesis and Pathophysiology

The etiology of the other hereditary red-cell membrane disorders lies in germline variants affecting genes that encode structural proteins, ion channels and red-cell membrane transporters. Each form has a distinct genetic basis, with inheritance generally autosomal dominant but also autosomal recessive variants and, rarely, de novo mutations.

Major genes and proteins involved in the most clinically relevant forms include:

• PIEZO1: encodes a mechanosensitive ion channel central to dehydrated hereditary stomatocytosis, or hereditary xerocytosis. Gain-of-function variants cause abnormal membrane ion permeability.
• KCNN4: encodes a calcium-activated potassium channel involved in some forms of dehydrated stomatocytosis or hereditary xerocytosis.
• SLC4A1: encodes band 3, the chloride-bicarbonate anion exchanger, which is abnormal in Southeast Asian ovalocytosis (SAO).
• SPTA1, SPTB, EPB41: genes encoding membrane-skeleton proteins, including alpha- and beta-spectrin and protein 4.1, involved in hereditary pyropoikilocytosis, a severe form within the elliptocytosis spectrum, and in other complex membrane disorders.

Phenotype modifiers depend on the specific diagnosis. Infections may worsen anemia; coexistence of other red-cell defects may alter the phenotype. In PIEZO1 channelopathies, pregnancy is associated mainly with fetal edema or hydrops, whereas splenectomy greatly increases thromboembolic risk.

Pathogenic mechanisms are closely related to the function of the affected protein:

• Overhydrated hereditary stomatocytosis: Classically associated with RHAG variants that increase net cation influx, leading to intracellular sodium and water accumulation. Red blood cells enlarge, lose their normal biconcavity and develop the characteristic slit-like central pallor of stomatocytes. Abnormal hydration and deformability shorten red-cell survival and cause chronic hemolysis of variable severity, without requiring the disorder to be described as predominantly intravascular.
• Hereditary xerocytosis (dehydrated hereditary stomatocytosis): Gain-of-function variants in PIEZO1 and KCNN4 promote potassium and water loss, causing red-cell dehydration, increased cell density and formation of xerocytes, flattened, hyperchromic and irregular red blood cells. The cells are more resistant to osmotic lysis but undergo chronic hemolysis and premature destruction that is not exclusively splenic and may persist after splenectomy. This red-cell membrane channelopathy is associated with a high risk of venous thrombosis after splenectomy.
• Hereditary pyropoikilocytosis: a severe disorder within the hereditary elliptocytosis spectrum. The common infantile form often results from an SPTA1 variant associated with elliptocytosis in trans with the low-expression alpha^LELY allele; persistent forms may also result from biallelic or compound variants in SPTA1, SPTB or EPB41. Red blood cells show marked poikilocytosis, fragmentation, microspherocytes and heat sensitivity. Severity is variable: some forms present in the neonatal period with transfusion-dependent anemia, whereas the common infantile form may lessen during the first years of life and evolve toward an elliptocytosis phenotype.
• Southeast Asian ovalocytosis (SAO): a deletion in SLC4A1 causes marked red-cell rigidity and an oval shape. Heterozygotes are generally asymptomatic or mildly hemolytic; rare homozygous or compound forms can be compatible with live birth and cause severe neonatal phenotypes. SAO confers partial protection against severe malaria.
• Other rare forms: Combined band 3 and spectrin defects and abnormalities of accessory membrane proteins, with variable phenotypes that often fall outside traditional classifications.

In hemolytic forms, pathophysiology can be summarized as reduced red-cell survival due to mechanical fragility, abnormal responses to osmotic stress and, in some cases, altered ion permeability. The hemolytic pattern varies by disorder: many cytoskeletal forms have an extravascular component, whereas in red-cell channelopathies hemolysis is not necessarily predominantly splenic and may persist after splenectomy. In the most severe forms, such as pyropoikilocytosis and overhydrated stomatocytosis, hemolysis can become acutely severe and require repeated transfusions in childhood.

Chronic abnormalities of red-cell morphology influence the clinical course: loss of normal biconcavity reduces red-cell flexibility in capillaries, promotes splenic sequestration and marrow hyperplasia, contributes to skeletal deformities and, in some forms, increases the risk of aplastic crises and vascular complications.

Clinical Manifestations

The clinical manifestations of the other red-cell membrane disorders are extremely variable, ranging from nearly silent phenotypes to severe hemolytic anemia with neonatal onset, risk of hydrops fetalis, acute hemolytic crises, thrombotic complications and multiorgan involvement.

Common clinical features include:

• Chronic anemia of variable severity: from mild disease with stable hemoglobin and minimal symptoms to severe anemia in newborns with pyropoikilocytosis or overhydrated stomatocytosis. Anemia is typically normocytic or mildly microcytic or macrocytic depending on the predominant disorder.
• Intermittent or persistent jaundice: a common consequence of hemolysis, often with increased indirect bilirubin and a risk of kernicterus in newborns, especially in severe forms.
• Splenomegaly: a variable finding, more marked in chronic disease or forms complicated by extramedullary hematopoiesis.
• Acute worsening of anemia: may be associated with infections, pregnancy or other stressors; Parvovirus B19 typically causes an aplastic crisis through erythroid suppression rather than a hemolytic crisis. Rapid worsening of anemia may require urgent transfusion.
• Gallstones: secondary to chronic hyperbilirubinemia, very common in adults and an important cause of recurrent abdominal pain and surgical complications.

Some subtypes have additional distinctive features:

• Overhydrated hereditary stomatocytosis: chronic hemolytic anemia of variable severity, stomatocytes on the blood smear and macrocytosis; severe forms may present in the neonatal period.
• Dehydrated hereditary stomatocytosis (hereditary xerocytosis): often compensated hemolytic anemia, variable jaundice and splenomegaly, iron overload even without transfusions and a high thrombotic risk after splenectomy. Pregnancy is associated mainly with fetal or perinatal complications such as edema and hydrops.
• Hereditary pyropoikilocytosis: very severe anemia in the first months of life, often requiring red-cell transfusions, with marked anisopoikilocytosis, microspherocytes and immature reticulocytes and episodes of massive hemolysis during infections; exchange transfusion may be required for extreme neonatal hyperbilirubinemia.
• Southeast Asian ovalocytosis: generally asymptomatic in heterozygotes but may be associated with variable hemolysis. Rare biallelic forms compatible with live birth can cause severe neonatal anemia and complications.

Over the long term, severe forms may cause growth delay, skeletal abnormalities from marrow expansion, splenomegaly and complications of iron overload. In dehydrated stomatocytosis, splenectomy carries risks of venous thrombosis, pulmonary embolism and pulmonary hypertension.

Clinical presentation may change substantially over a lifetime because of interactions with environmental factors such as infections, pregnancy and drugs, progression of chronic hemolysis and iron-overload complications, and adverse effects of treatments such as splenectomy, repeated transfusions and iron chelation.

Despite a tendency toward chronic manifestations, some individuals remain essentially asymptomatic and are diagnosed only in adulthood during evaluation of persistent anemia, gallstones or unexpected thrombotic complications.

Diagnostic Evaluation

The diagnosis of other hereditary red-cell membrane disorders requires a structured pathway combining medical history, clinical findings, conventional and advanced laboratory tests and, increasingly, second-line molecular analysis. The process begins with clinical and morphological suspicion and integrates functional testing and, when indicated, molecular analysis. Genetic definition is particularly useful in atypical, severe or transfusion-dependent cases, when phenotypic tests are inconclusive, or when the result may alter treatment or family counseling, but it is not essential in every patient.

Diagnostic suspicion typically arises in the presence of:

• Unexplained chronic hemolytic anemia with persistent reticulocytosis, increased indirect bilirubin and LDH but no evidence of immune hemolysis, with a negative direct antiglobulin test.
• Red-cell morphological abnormalities on peripheral smear that differ from classic spherocytosis or elliptocytosis, such as stomatocytes with a longitudinal slit-like central pallor, xerocytes hyperchromic flat red blood cells with reduced central pallor, poikilocytes and bizarre-shaped cells.
• Unexplained splenomegaly, gallstones at a young age, episodes of acute hemolytic crises, or a family history of chronic anemia with a similar phenotype.

The complete blood count typically shows:

• Normocytic or mildly microcytic or macrocytic anemia, often compensated by marked reticulocytosis.
• Polychromasia and increased young red cells or reticulocytes.
• In some forms, a normal or increased red-cell count despite anemia.

The peripheral blood smear is essential for recognizing different patterns:

• Overhydrated hereditary stomatocytosis: stomatocytes in 10–50% of red blood cells, often with anisopoikilocytosis and occasional xerocytes.
• Hereditary xerocytosis: peripheral morphology is often nonspecific, with absent, rare or few stomatocytes and possible target cells or dense, dehydrated red cells; osmotic ektacytometry is much more characteristic than the smear.
• Pyropoikilocytosis: marked anisopoikilocytosis, schistocytes, microspherocytes, poikilocytes, fragmented red blood cells, abnormal forms and numerous reticulocytes.
• Southeast Asian ovalocytosis: markedly oval red blood cells, often with a central slit and very uniform morphology; normal red cells are also present in heterozygotes.

Expert assessment is essential because the proportion of abnormal cells may be modest or masked by concurrent conditions.

Functional membrane tests:

• Osmotic fragility test: may be abnormal but less characteristically than in spherocytosis; in xerocytes, osmotic fragility may paradoxically be reduced because cells are more resistant to hypotonic lysis.
• Direct measurement of ion fluxes: specialist tests quantify sodium and potassium permeability and are available only in referral laboratories. The eosin-5-maleimide binding test primarily assesses band 3 by flow cytometry, whereas ektacytometry measures red-cell deformability across an osmotic gradient.
• Ektacytometry: assesses red-cell deformability across an osmotic gradient and provides a characteristic signature for different membrane disorders, for example distinguishing stomatocytosis from xerocytosis or spherocytosis.

Differential diagnosis: The main differential diagnoses of hereditary red-cell membrane disorders are:

• Hereditary spherocytosis and elliptocytosis: because they also cause chronic hemolytic anemia and splenomegaly, but have different red-cell morphology and family patterns.
• Acquired hemolytic anemias, including autoimmune, microangiopathic and toxic forms: distinction requires integration of history, morphology, DAT, clinical course and specific tests; DAT negativity alone is not discriminatory.
• Hemoglobin disorders and red-cell enzymopathies, including G6PD and pyruvate kinase deficiency: in which red-cell morphology, hemolytic pattern and biochemical testing differ.

Other red-cell membrane disorders should always be considered when atypical morphology, unexplained splenomegaly or chronic hemolysis is present, particularly in patients from high-prevalence regions or with a positive family history.

Genetic analysis: Molecular identification of the causative variant in PIEZO1, KCNN4, SLC4A1, SPTA1 or other genes is important for confirmation and etiologic definition and should be integrated with phenotype, morphology and membrane functional testing, especially ektacytometry when available. Testing is based on direct sequencing of candidate genes or, in uncertain cases, next-generation sequencing panels for hereditary anemias. It is particularly useful in ultra-rare forms, for identifying asymptomatic carriers and for preventing complications, such as appropriately avoiding splenectomy in high-thrombotic-risk disorders.

Second-line investigations: In severe anemia, massive splenomegaly or organ complications, appropriate investigations include:

• Abdominal ultrasound: assessment of spleen and liver, gallstones, and signs of portal hypertension.
• Liver, renal and cardiac function tests: to assess organ injury from chronic hemolysis or treatment complications.
• Assessment of iron metabolism: ferritin, serum iron and transferrin saturation, especially in transfused patients or those with hyperferritinemia.

Family screening: In hereditary forms, family screening may include clinical, hematologic and morphological assessment. Genetic testing of relatives should be performed when it can clarify the inheritance pattern, identify relevant variants or provide useful information for genetic counseling.

Treatment and Prognosis

Management of other hereditary red-cell membrane disorders is individualized according to clinical severity, age, thrombotic and infectious risk, and comorbidities.

Supportive treatment:

• Periodic monitoring of hematologic parameters such as hemoglobin, reticulocytes, bilirubin and LDH.
• Transfusion support for severe anemia, acute hemolytic worsening or major surgery.
• Prevention and treatment of gallstones, including periodic ultrasound and cholecystectomy when indicated.
• Management of skeletal, nutritional and endocrine complications in patients with chronic anemia.

Splenectomy: The decision to perform splenectomy in non-stomatocytic membrane disorders requires a precise diagnosis integrating phenotype, functional tests and, when indicated, genetics. Splenectomy is contraindicated in hereditary stomatocytoses because of the high thromboembolic risk; iron overload requires separate management and is not the reason for the contraindication.

Treatment of hemolytic crises: Management requires transfusion support when indicated, treatment of precipitating causes, especially infections, and clinical monitoring. Pregnancy in PIEZO1 channelopathies requires particular surveillance because of fetal or perinatal complication risk. An aplastic crisis due to Parvovirus B19 may require hospitalization and intensive supportive care.

Prevention of thrombotic complications: Patients at high risk, especially after splenectomy, require surveillance for deep-vein thrombosis, pulmonary embolism and pulmonary hypertension. Any antithrombotic prophylaxis should be individualized by a specialist.

Innovative therapies: No approved molecular therapies currently correct PIEZO1, KCNN4 or other membrane defects. Pharmacologic and gene-based approaches remain preclinical or experimental and have no demonstrated clinical efficacy.

Genetic counseling: Essential for all affected families to define reproductive risk, identify at-risk relatives and discuss available reproductive options in a nondirective manner.

Prognosis: Prognosis varies greatly according to the genetic disorder and quality of follow-up. In patients diagnosed early and managed at specialist centers, survival may approach that of the general population, although morbidity from hemolytic, biliary and thrombotic complications remains increased. Severe forms may present with profound anemia and neonatal complications; pyropoikilocytosis may improve with age, whereas overhydrated stomatocytosis has a chronic hemolytic course of variable severity. Mortality risk is linked mainly to thromboembolic complications and unrecognized acute hemolytic events.

A multidisciplinary approach involving hematology, internal medicine, genetics and psychological support is the current standard of care, ensuring adequate quality of life and prevention of major long-term complications.

Complications

The complications of the other red-cell membrane disorders result from chronic hemolysis, specific red-cell membrane abnormalities and adverse effects of treatments such as splenectomy and transfusions. Major complications include:

• Gallstones: a consequence of chronic hyperbilirubinemia and very common even at a young age.
• Massive splenomegaly and hypersplenism: with cytopenias such as anemia, leukopenia and thrombocytopenia and risk of splenic rupture.
• Acute worsening of anemia: especially during infections; severe neonatal forms may require urgent transfusion support.
• Thromboembolic complications: very high risk in dehydrated stomatocytosis after splenectomy, including deep-vein thrombosis, pulmonary embolism and pulmonary hypertension.
• Iron-overload complications: clinically relevant in dehydrated stomatocytosis even without transfusions, as well as in patients receiving repeated transfusions.
• Skeletal abnormalities: growth delay, osteopenia and skeletal deformities in chronic marrow hyperplasia.
• Infectious complications: especially in splenectomized patients, with risk of infection from encapsulated organisms such as pneumococcus, meningococcus and Haemophilus influenzae and of overwhelming sepsis.
• Psychosocial complications: anxiety, depression and difficulties with school and social integration, especially in children with severe disease.

Overall complication risk and severity depend on early diagnosis, adherence to periodic follow-up and appropriate management of acute episodes and comorbidities. Prevention, including vaccination, family screening and genetic counseling, is an integral part of follow-up.

Bibliography
1. Delaunay J. The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations. Semin Hematol. 2004;41(2):165–172.
2. Flatt JF, Bruce LJ. The hereditary stomatocytoses. Haematologica. 2009;94(8):1039–1041.
3. Frederiksen H. Dehydrated hereditary stomatocytosis: clinical perspectives. J Blood Med. 2019;10:183–191.
4. Kalfa TA. Diagnosis and clinical management of red cell membrane disorders. Hematology Am Soc Hematol Educ Program. 2021;2021(1):331–340.
5. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939–3948.
6. King MJ, Garçon L, Hoyer JD, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;37(3):304–325.
7. Narla J, Mohandas N. Red cell membrane disorders. Int J Lab Hematol. 2017;39 Suppl 1:47–52.
8. Gallagher PG. Red cell membrane disorders. Hematology Am Soc Hematol Educ Program. 2005:13–18.
9. Da Costa L, Galimand J, Fenneteau O, Mohandas N. Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev. 2013;27(4):167–178.
10. Zarychanski R, Schulz VP, Houston BL, et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood. 2012;120(9):1908–1915.
11. Andolfo I, Alper SL, De Franceschi L, et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood. 2013;121(19):3925–3935.
12. Picard V, Guitton C, Thuret I, et al. Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients. Haematologica. 2019;104(8):1554–1564.
13. Albuisson J, Murthy SE, Bandell M, et al. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nat Commun. 2013;4:1884.
14. Stewart GW. Hemolytic disease due to membrane ion channel disorders. Curr Opin Hematol. 2004;11(4):244–250.
15. Bae C, Gnanasambandam R, Nicolai C, et al. Xerocytosis is caused by mutations that alter the kinetics of the mechanosensitive channel PIEZO1. Proc Natl Acad Sci U S A. 2013;110(12):E1162–E1168.